MENU
+Compare
SARTF
Stock ticker: OTC
AS OF
Dec 1 closing price
Price
$220.00
Change
+$23.51 (+11.96%)
Capitalization
17.77B

SARTF Sartorius AG Forecast, Technical & Fundamental Analysis

Sartorius AG is a leading provider of bioprocessing solutions... Show more

SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SARTF with price predictions
Nov 28, 2025

SARTF in downward trend: 10-day moving average broke below 50-day moving average on November 24, 2025

The 10-day moving average for SARTF crossed bearishly below the 50-day moving average on November 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SARTF as a result. In of 63 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SARTF turned negative on November 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

SARTF moved below its 50-day moving average on November 18, 2025 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SARTF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 114 cases where SARTF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SARTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.895) is normal, around the industry mean (9.233). P/E Ratio (98.039) is within average values for comparable stocks, (163.343). Projected Growth (PEG Ratio) (0.753) is also within normal values, averaging (2.548). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (3.713) is also within normal values, averaging (110.831).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SARTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

SARTF paid dividends on March 31, 2021

Sartorius AG SARTF Stock Dividends
А dividend of $0.70 per share was paid with a record date of March 31, 2021, and an ex-dividend date of March 29, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Otto-Brenner-Strasse 20
Phone
+49 5513080
Employees
14614
Web
https://www.sartorius.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QTJA29.630.07
+0.24%
Innovator Growth Accelerated Pls ETF Jan
SCHZ23.440.02
+0.09%
Schwab US Aggregate Bond ETF™
HMOP39.100.02
+0.06%
Hartford Municipal Opportunities ETF
VLLU23.18N/A
+0.01%
Harbor AlphaEdge Large Cap Value ETF
TOLZ54.18-0.49
-0.90%
ProShares DJ Brookfield Global Infras

SARTF and Stocks

Correlation & Price change

A.I.dvisor tells us that SARTF and SOAGY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SARTF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SOAGY - SARTF
25%
Poorly correlated
N/A
RVTY - SARTF
25%
Poorly correlated
+0.33%
SRTOY - SARTF
24%
Poorly correlated
N/A
EXAS - SARTF
24%
Poorly correlated
-0.02%
WAT - SARTF
21%
Poorly correlated
+0.20%
More

Groups containing SARTF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
Pharmaceuticals: Other
industry (103 stocks)
15%
Poorly correlated
+0.77%
Pharmaceuticals
industry (377 stocks)
14%
Poorly correlated
+0.67%